
Bioventus BVS
$ 7.53
-0.26%
Quarterly report 2025-Q3
added 11-04-2025
Bioventus DPO Ratio 2011-2025 | BVS
Annual DPO Ratio Bioventus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.2 | 54 | 24.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 59.2 | 24.1 | 45.8 |
Quarterly DPO Ratio Bioventus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.3 | 43.5 | 40.3 | 41.5 | 41.8 | 40.8 | 64.2 | 70.6 | 70.3 | - | 46.3 | 50.4 | 43.2 | - | 31.8 | 27.5 | 30.2 | - | 17.2 | 22.8 | 9.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 70.6 | 9.42 | 41.3 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 101.5 | - | $ 18.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.66 | 5.75 % | $ 179 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.57 | -3.4 % | $ 2 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 38.42 | -0.54 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 11.98 | 0.76 % | $ 340 M | ||
|
DexCom
DXCM
|
70.4 | $ 65.76 | -1.79 % | $ 25.4 B | ||
|
Danaher Corporation
DHR
|
66.4 | $ 226.02 | -0.21 % | $ 165 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 26.95 | -0.7 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 19.75 | -3.94 % | $ 1.06 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.37 | -5.86 % | $ 107 K | ||
|
Co-Diagnostics
CODX
|
106 | $ 0.31 | -9.72 % | $ 9.1 M | ||
|
IQVIA Holdings
IQV
|
126 | $ 222.26 | 0.02 % | $ 40.3 B | ||
|
Guardant Health
GH
|
83.6 | $ 103.49 | 1.39 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
56.3 | $ 134.29 | -0.43 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 196.54 | 1.84 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 183.1 | 0.32 % | $ 20.3 B | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 407.75 | 0.99 % | $ 29.9 B | ||
|
Myriad Genetics
MYGN
|
42 | $ 6.97 | -3.33 % | $ 631 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 260.62 | -1.35 % | $ 21.9 B | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 182.8 | -2.03 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
27 | $ 699.0 | -0.74 % | $ 57.6 B | ||
|
NeoGenomics
NEO
|
20.7 | $ 12.06 | 1.73 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 6.79 | -1.09 % | $ 1.47 B | ||
|
Lantheus Holdings
LNTH
|
25.3 | $ 67.14 | 0.78 % | $ 4.65 B | ||
|
Agilent Technologies
A
|
50.1 | $ 140.44 | 0.56 % | $ 42.7 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.43 | -5.89 % | $ 5.58 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Pacific Biosciences of California
PACB
|
33.5 | $ 2.11 | -0.47 % | $ 535 M |